FARMACID
FARMACID S.A. is a Quito, Ecuador-based pharmaceutical contract manufacturer producing GMP-certified sterile and non-sterile drug forms for multinational and regional pharmaceutical clients across Latin America, including Merck, MSD, Grünenthal, and Siegfried, with integrated quality control, packaging, stability, and distribution services.
- Company typePrivate
- Founded2000
- HeadquartersQuito, Ecuador
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What FARMACID does
FARMACID S.A. is a Quito-based pharmaceutical contract manufacturing organization (CMO) operating a single integrated production platform that manufactures sterile and non-sterile pharmaceutical forms for both domestic and international pharmaceutical companies. The company's manufacturing scope covers small-volume parenteral solutions (ampoules), ophthalmic solutions, sterile powders for injection, oral solids (capsules, tablets, coated and controlled-release tablets), semi-solids (creams, ointments, gels), and non-sterile liquids (oral, nasal, ear solutions, suspensions, emulsions). Production occurs in a modern plant originally acquired from Schering-Plough del Ecuador in 2000 (with prior operations dating to 1977), featuring Class 100 filling areas with Class 10,000 support areas, multi-stage water treatment (demineralization, reverse osmosis, distillation), and an in-house quality control laboratory equipped with HPLC GRS chromatographs, TOC analyzers, and IR equipment for physical, chemical, and microbiological analysis. The facility holds GMP and ISO 9001 certifications and runs at approximately 1,200,000 units of monthly production capacity on 8-hour shifts, with headcount of roughly 116 employees firmographic (and ~150 contributing to production operations per internal notes).
The company's go-to-market is B2B sales-led, targeting pharmaceutical companies that require GMP-compliant contract manufacturing without investing in their own production infrastructure. Its named client roster includes multinational pharmaceutical majors (Merck, MSD, Grünenthal, Siegfried) and regional/Ecuadorian firms (MAVER Chile, Pharmabrand, CID Botanicals). Revenue is generated through contract manufacturing fees for produced units, supplemented by integrated service revenue from quality control testing, stability studies (including for the United States market), packaging across multiple formats, and temperature/humidity-controlled storage and distribution including cold chain (with local 24-hour and national 48-hour delivery service levels). Distribution is primarily direct and national in scope, with exports to South America and broader Latin America markets. The firm is privately held (no parent company, no institutional investors, no public listing) under the leadership of General Manager Roberto Cid Vivanco.
FARMACID firmographics
Firmographics- Name
- FARMACID
- Legal name
- FARMACID S.A.
- Website
- https://farmacid.com.ec
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- FARMACID S.A. is a Quito, Ecuador-based pharmaceutical contract manufacturer producing GMP-certified sterile and non-sterile drug forms for multinational and regional pharmaceutical clients across Latin America, including Merck, MSD, Grünenthal, and Siegfried, with integrated quality control, packaging, stability, and distribution services.
- Ownership category
- akta.pro rank
Where FARMACID is headquartered
LocationHeadquarters
- HQ city
- Quito
- HQ country
- Ecuador
- HQ region
- Latin America
Offices1 record
Markets served
FARMACID business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Contract Pharmaceutical Manufacturing: FARMACID operates as a contract manufacturing organization (CMO) for pharmaceutical products. They manufacture sterile and non-sterile pharmaceutical forms for other pharmaceutical companies and also for their own product portfolio. Revenue comes from manufacturing fees for produced units, as well as providing related services like quality control testing, stability studies, and storage/distribution.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
FARMACID product offering
Product offeringCore offering
FARMACID is a pharmaceutical contract manufacturing organization that produces sterile and non-sterile drug forms — including sterile liquids (ampoules, pre-filled syringes, ophthalmic solutions), sterile powders, oral solids (capsules, tablets, granules), semi-solids (creams, ointments, gels), and non-sterile liquids — for pharmaceutical companies. Integrated services include quality control testing, pharmaceutical packaging, stability studies, and temperature-controlled storage and distribution.
Product overview
FARMACID S.A. is a pharmaceutical manufacturing company operating as a single unified manufacturing platform with integrated services. The company produces sterile and non-sterile pharmaceutical products for human use, organized into: (1) Sterile Liquids and Sterile Powders (injection solutions, ophthalmic products), (2) Non-Sterile Solids (capsules, tablets, granules), (3) Semi-Solids (creams, ointments, gels), and (4) Non-Sterile Liquids (oral, nasal, ear solutions, suspensions). These core products are supported by integrated service modules including Quality Control Services (physical, chemical, and microbiological testing), Packaging Services (blister, liquid, cream packaging lines), Storage and Distribution Services (with cold chain capabilities), and Stability Studies Services (pilot transfers and product development). The company operates from a modern plant acquired from Schering-Plough in 2000, with capacity of approximately 1,200,000 units monthly.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Liquids
Quantifiable outcome
- Production capacity of approximately 1,200,000 units per month
- +1 more outcomes
Companies that use FARMACID
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles1 record
FARMACID technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
FARMACID partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor.
- MerckminorPharmaceutical company featured as a client of FARMACID. Merck is a global pharmaceutical company.
- MSDminorPharmaceutical company featured as a client of FARMACID. MSD is a global healthcare company.
- GrünenthalminorPharmaceutical company featured as a client of FARMACID. Grünenthal is a pharmaceutical company specializing in pain management.
- SiegfriedminorPharmaceutical company featured as a client of FARMACID. Siegfried is a contract pharmaceutical manufacturer.
- MAVER (Chile)minorPharmaceutical company from Chile featured as a client of FARMACID.
- PharmabrandminorEcuadorian pharmaceutical company featured as a client of FARMACID.
- CID BotanicalsminorPharmaceutical/natural products company featured as a client of FARMACID.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
FARMACID competitors and assessment
Company assessmentDirect peers
- Siegfried Holding AG: Swiss-headquartered pharmaceutical CDMO offering sterile and non-sterile manufacturing, packaging and quality services globally. Directly comparable to FARMACID as a contract manufacturer serving pharma clients across multiple dosage forms.
- Recipharm: European CDMO offering sterile and non-sterile contract manufacturing, serialization and analytical services. Directly comparable to FARMACID in business model and pharmaceutical manufacturing scope.
- Piramal Pharma Solutions: Global CDMO offering sterile injectables, oral solids, APIs and analytical services. Comparable to FARMACID as a contract manufacturer serving pharma clients across sterile and non-sterile dosage forms.
- Aenova Group: European pharmaceutical CDMO offering solid, semi-solid, liquid and sterile manufacturing plus packaging. Comparable to FARMACID in contract manufacturing across multiple dosage forms for pharma clients.
- Patheon (Thermo Fisher Scientific): Global pharmaceutical CDMO within Thermo Fisher offering contract development and manufacturing across sterile, oral solid and liquid dose forms. Directly comparable service model and customer base to FARMACID.
- Almac Group: Global CDMO providing contract pharmaceutical development, manufacturing and analytical services including sterile and oral dose forms. Comparable to FARMACID in offering integrated services to pharma clients.
- Catalent: Global pharmaceutical CDMO with deep sterile injectable and oral dose capabilities. Comparable to FARMACID in offering integrated contract manufacturing, packaging and analytical services to multinational pharma clients.
Regional players
- Eurofarma: Brazilian multinational pharmaceutical company with vertically integrated manufacturing of sterile, solid and semi-solid dosage forms across Latin America. Comparable to FARMACID as a regional pharma manufacturer with similar dosage-form breadth.
- EMS Pharma: Brazilian pharmaceutical manufacturer producing solid, liquid, semi-solid and sterile dosage forms with broad Latin American distribution. Comparable to FARMACID as a regional pharma manufacturer with similar manufacturing scope.
- Aché Laboratórios: Brazilian pharmaceutical company with in-house sterile and non-sterile manufacturing capabilities serving Latin American markets. Comparable to FARMACID as a regional pharma manufacturer with GMP-certified production and similar dosage-form portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
FARMACID social profiles
Digital presenceFARMACID compliance and trust
Trust signalCompliance3 records
FARMACID financial estimates
Financial estimateRevenue estimate
Valuation estimate
FARMACID leadership team
Management profileNumber of profiles
Profiles1 record
FARMACID funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FARMACID M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FARMACID
What does FARMACID do?
FARMACID is a pharmaceutical contract manufacturing organization that produces sterile and non-sterile drug forms — including sterile liquids (ampoules, pre-filled syringes, ophthalmic solutions), sterile powders, oral solids (capsules, tablets, granules), semi-solids (creams, ointments, gels), and non-sterile liquids — for pharmaceutical companies. Integrated services include quality control testing, pharmaceutical packaging, stability studies, and temperature-controlled storage and distribution.
Is FARMACID a public or private company?
FARMACID is a private company. It is classified as unknown and is currently operating.
When was FARMACID founded?
FARMACID was founded in 2000. It employs 101 to 250 people.
Where is FARMACID based?
FARMACID is headquartered in Quito, Ecuador, in the Latin America region.
How does FARMACID make money?
One revenue line is on record: contract Pharmaceutical Manufacturing.
Who are FARMACID's main competitors?
Direct peers on record are Siegfried Holding AG, Recipharm, Piramal Pharma Solutions, Aenova Group, Patheon (Thermo Fisher Scientific), Almac Group and Catalent. Regional players are Eurofarma, EMS Pharma and Aché Laboratórios.
Does FARMACID have an API?
No public API is recorded for FARMACID.